Its expression is correlated with various aspects of cancer progression, including chemotherapeutic drug resistance, cell growth, and stemness properties through the activation of the AKT/ERK and c-Src/β-catenin signaling pathways [12]. The gene discussed is AKT1; the disease is cancer.